The Aplastic Anemia market presents opportunities in novel therapies, with 5+ companies and 8+ drugs in various development stages. Key focus is on innovative treatment approaches, partnerships, and ...

Shares of Akebia Therapeutics fell sharply premarket after it abandoned plans for a clinical trial of its anemia treatment in patients not on kidney dialysis following a meeting with the Food and Drug ...

The proposed trial aimed to study the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease not on dialysis. The treatment is already approved for such patients who have ...

Disc Medicine, Inc. (($IRON)) announced an update on their ongoing clinical study. Disc Medicine, Inc. is conducting a study titled RALLY-MF: A ...

Studies show patients with chronic kidney disease (CKD) and COVID-19 are at increased risk for an intensive care unit stay and early death. Anemia is an extra risk factor.

Skin conditions, diet choices, and some chronic health conditions may make the bottom of your feet yellow. Treating the cause ...